SYRA HEALTH CORP. — Earnings

Most recent reported period: FY2025 (Q4) (filed for period ending 2025-12-31) · sourced from SEC EDGAR

Next earnings (estimated): Wed, April 1, 2026 28 days overdue (likely already filed but EDGAR cache cold). Anchored to latest quarter-end + 91 days. Analyst-confirmed dates land in a follow-up wave.
YoY = vs same quarter prior year (seasonality-adjusted)

Recent earnings · last 8 quarters

Quarter endRevenueYoYNet IncomeYoYOp. Margin
2025-12-31$2M↓-13.6%
2025-09-30$2M↓-25.1%$-226K↑+45.9%-13.8%
2025-06-30$2M↓-1.2%$-64K↑+95.4%-3.2%
2025-03-31$2M↑+6.0%$-472K↑+67.4%-25.5%
2024-12-31$2M↑+13.6%
2024-09-30$2M↑+42.5%$-418K↓-17.8%-19.0%
2024-06-30$2M↑+101.1%$-1M↓-73.2%-70.6%
2024-03-31$2M↑+47.5%$-1M↓-84.1%-82.4%

Analyst consensus estimates (EPS / Revenue) and implied move from options will land in a follow-up wave. For now, YoY-vs-prior-year-quarter is the surprise proxy.

Last earnings · FY2025 (Q4)

Revenue
$2M
↓-13.6% -$273K YoY
Net Income
$348K
↑+109.6% +$182K YoY

Earnings surprise · last 8 quarters

YoY % change · proxy for analyst surprise until estimates land

EPS history · last 10 fiscal years

diluted, GAAP, annual

Note: EPS reflects WEIGHTED-AVERAGE diluted shares for each fiscal year. Pre-stock- split values can blow up the early bars if SEC's XBRL data isn't split-adjusted — flagged as a known limitation; cumulative split-adjustment is a follow-up.

Margin trends · 14 quarters

margin trajectory tells the operating-leverage story
Gross Margin↑+17.4pts
34.1%
Operating Margin↑+5.3pts
-13.8%
Net Margin↑+5.1pts
-13.4%

Go deeper